Chiara C.
- Country
- Italy
- Department
- DAI Area Medica Oncologica - UOC Oncologia medica 2
Research Overview
- Phase 1b/2 Study of 5-Fluorouracil, Leucovorin, Irinotecan, Temozolomide, and Bevacizumab in MGMT Silenced, Microsatellite Stable Metastatic Colorectal Cancer
- Evaluation of Sotorasib (AMG 510) in Patients with Advanced Solid Tumors Harboring KRAS p.G12C Mutation: A Master Protocol Study
- A Phase I/II Study of AMG 410 Monotherapy and Combination Therapy in Participants with KRAS-Altered Advanced or Metastatic Solid Tumors
Data & Insights
Has run more than one trial at 279 of 524 partner sites.
Specializations
Colorectal Cancer Treatment
Specializes in innovative approaches for treating metastatic colorectal cancer, with particular focus on molecular-targeted therapies and biomarker-driven treatment strategies.
- KRAS/BRAF wild-type therapies
- HER2-positive colorectal cancer treatments
- MSI-H/dMMR targeted approaches
Extensive experience in developing treatment protocols for various stages of colorectal cancer, from early-stage to advanced disease.
Precision Medicine Applications
Focuses on biomarker-driven treatment strategies and personalized therapeutic approaches in gastrointestinal cancers.
- Liquid biopsy applications
- Molecular profiling
- Targeted therapy combinations
Investigates novel combinations of targeted therapies with standard treatments to improve patient outcomes.
Advanced Cancer Research
Conducts research in advanced gastrointestinal malignancies, including pancreatic cancer and gastric cancer.
- Novel therapeutic approaches
- Immunotherapy combinations
- Treatment resistance mechanisms
Specializes in developing innovative treatment strategies for patients with advanced-stage cancers.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.